Shannon Aymes, MD

NBTS launched a clinical trial finder specific to brain tumors to engage patients in research and clinical trials.

Risk for cardiac events linked to RT for locally advanced NSCLC, especially in patients with a history of cardiac disease or receiving higher RT doses.

Prospective pilot study demonstrates accuracy of circulating tumor cells as a biomarker indicating lung cancer recurrence.

Hypofractionated regimen of precision radiotherapy was not inferior to conventional RT in patients with intermediate-risk prostate cancer.

AYAs continue to report lower social functioning scores than their peers 2 years after diagnosis.

Standardized palliative care consultations for patients with advanced cancer improved postdischarge activities and use of services.

Patients were more comfortable with their decisions about lung cancer screening after a shared decision-making visit.

The addition of temozolomide to short-course radiotherapy in elderly patients with glioblastoma was associated with some survival benefit compared with radiotherapy alone.

Genetic signatures similar to BRCA1/BRCA2 mutations could make PARP inhibition a treatment option for some breast cancers.

Exercise helps patients with gastrointestinal cancer undergoing chemotherapy cope with their disease and treatment.